St. Jude Research

2019 Archive

Blazing through new territory to fight a devastating neurodegenerative disease
Blazing through new territory to fight a devastating neurodegenerative disease
Research

Blazing through new territory to fight a devastating neurodegenerative disease

 St. Jude Communications Department

Read how researchers have found a path to control coenzyme A and possibly prevent a devastating neurodegenerative disease.

Why I strive to be like my mentor
Why I strive to be like my mentor
Outreach

Why I strive to be like my mentor

 Dillon Robinson

Read how mentoring transformed a small-town college student into an epidemiologist.

Postdoc survival guide: On the road to discovery, you’re allowed to stumble at first
Postdoc survival guide: On the road to discovery, you’re allowed to stumble at first
Investigator Insights

Postdoc survival guide: On the road to big discovery, you’re allowed to stumble on your first steps

 Anthony Zamora, PhD

New lab, new investigators, new personalities, new team – learn how to make it in your first year as a postdoc.

Does obesity give influenza more time to spread and impair flu vaccines?
Does obesity give influenza more time to spread and impair flu vaccines?
Research

Can obesity give influenza more time to spread and make vaccines less effective?

 Stacey Schultz-Cherry, PhD

St. Jude researchers, led by Dr. Stacey Schultz-Cherry, are asking questions about potential association between flu severity and the obesity epidemic.

Gut microbiome predicts infection risk in leukemia patients
Gut microbiome predicts infection risk in leukemia patients
Research

Gut microbiome sequencing opens new possibilities for predicting infection in leukemia patients

 St. Jude Communications Department

Researchers identify intestinal microbiota that may predict infection risk during chemotherapy in pediatric ALL patients. Learn about the gut microbiome.

New drug for a rare disorder: How will Gamifant’s approval affect HLH treatment?
New drug for a rare disorder: How will Gamifant’s approval affect HLH treatment?
Research

New drug for a rare disorder: How will Gamifant’s approval affect HLH treatment?

 Melissa Hines, MD

HLH, a rare disorder of the immune system, is caused by a buildup of proteins responding to infection. Read about a new treatment that limits that buildup.

Tumor microenvironment goes from homely to hostile when LAP is turned off
Tumor microenvironment goes from homely to hostile when LAP is turned off
Research

Tumor microenvironment switches from homely to hostile when this process is turned off

 Douglas R. Green, PhD

Researchers learn how this housekeeper for cancer cells turns into a cancer house killer. Learn how targeting LAP could promote an anti-tumor response and slow tumor growth.